Point72 Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9M Buy
137,000
+87,000
+174% +$8.33M 0.02% 1126
2025
Q4
$4.8M Sell
50,000
-66,900
-57% -$6.5M 0.01% 1876
2025
Q3
$11.1M Buy
116,900
+111,200
+1,951% +$10.2M 0.02% 751
2025
Q2
$497K Sell
5,700
-215,200
-97% -$18.3M ﹤0.01% 1788
2025
Q1
$19.9M Buy
220,900
+153,000
+225% +$13.7M 0.05% 451
2024
Q4
$5.42M Sell
67,900
-87,700
-56% -$7.59M 0.01% 923
2024
Q3
$14M Buy
155,600
+82,200
+112% +$6.92M 0.04% 534
2024
Q2
$5.78M Buy
73,400
+45,700
+165% +$3.75M 0.02% 795
2024
Q1
$2.41M Buy
27,700
+27,200
+5,440% +$2.32M 0.01% 1196
2023
Q4
$41.2K Hold
500
﹤0.01% 2020
2023
Q3
$39.2K Hold
500
﹤0.01% 2182
2023
Q2
$44K Hold
500
﹤0.01% 1633
2023
Q1
$40.3K Sell
500
-7,300
-94% -$595K ﹤0.01% 1827
2022
Q4
$606K Sell
7,800
-200
-3% -$16.2K ﹤0.01% 1127
2022
Q3
$646K Hold
8,000
﹤0.01% 1128
2022
Q2
$718K Buy
+8,000
New +$811K ﹤0.01% 1139
2018
Q1
Sell
-500,000
Closed -$40.4M 1054
2017
Q4
$40.4M Buy
+500,000
New +$40M 0.17% 160
2014
Q3
Sell
-250,000
Closed -$15.9M 717
2014
Q2
$15.9M Buy
+250,000
New +$15.2M 0.1% 240

Other funds holding MDT

Point72 Asset Management's MDT Position: Q3 2025 in Review

Point72 Asset Management sold out of Medtronic (MDT) in Q3 2025, closing a stake of 320,665 shares — an estimated $29.5M sold.

Point72 Asset Management first reported a position in MDT in Q2 2014 and held it in 33 quarters. The position peaked at $128M in Q4 2017. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • Point72 Asset Management reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • Point72 Asset Management sold 320,665 Medtronic shares in Q3 2025, an estimated $29.5M.
  • Point72 Asset Management first reported a position in Medtronic in Q2 2014 and held it in 33 quarters.
  • Point72 Asset Management's Medtronic position peaked at $128M in Q4 2017.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Point72 Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.